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Abstract
Background: Reduction of Lepeophtheirus salmonis infection in Atlantic salmon achieved by glucosinolates (GLs)
from Brassica plants was recently reported. However, wider application of functional feeds based on GLs requires
better knowledge of their positive and adverse effects.
Methods: Liver, distal kidney and muscle transcriptomes of salmon exposed to the extreme dose of GLs were
profiled by microarray, while qPCR analysis followed up selected hepatic and renal responses under the extreme
and moderate GLs dose during the L. salmonis challenge. Transcriptional analysis were complemented with
measurements of organ indices, liver steatosis and plasma profiling, including indicators of cytolysis and bilirubin.
Finally, the third trial was performed to quantify the effect of lower GLs doses on growth.
Results: The extreme GLs dose caused a decrease in hepatic fat deposition and growth, in line with microarray
findings, which suggested tissue remodeling and reduction of cellular proliferation in the skeletal muscle and liver.
Lower GLs inclusion levels in a follow-up trial did not show negative effects on growth. Microarray analysis of the
distal kidney pointed to activation of anti-fibrotic responses under the overexposure. However, analyses of ALT, CK
and AST enzymes in plasma provided no evidence of increased cytolysis and organ damage. Prevalent activation of
phase-2 detoxification genes that occurred in all three tissues could be considered part of beneficial effects caused
by the extreme dose of GLs. In addition, transcriptomic evidence suggested GLs-mediated iron and heme
withdrawal response, including increased heme degradation in muscle (upregulation of heme oxygenase-1),
decrease of its synthesis in liver (downregulation of porphobilinogen deaminase) and increased iron sequestration
from blood (hepatic induction of hepcidin-1 and renal induction of intracellular storage protein ferritin). This
response could be advantageous for salmon upon encountering lice, which depend on the host for the provision
of iron carrying heme. Most of the hepatic genes studied by qPCR showed similar expression levels in fish exposed
to GLs, lice and their combination, while renal induction of leptin suggested heightened stress by the combination
of extreme dose of GLs and lice. High expression of interferon γ (cytokine considered organ-protective in
mammalian kidney) was detected at the moderate GLs level. This fish also showed highest plasma bilirubin levels
(degradation product of heme), and had lowest number of attached lice, further supporting hypothesis that making
heme unavailable to lice could be part of an effective anti-parasitic strategy.
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Conclusions: Modulation of detoxification and iron metabolism in Atlantic salmon tissues could be beneficial prior
and during lice infestations. Investigation of anti-lice functional feeds based on low and moderate GLs inclusion
levels thus deserves further attention.
Keywords: Atlantic salmon, Salmo salar, Salmon louse, Lepeophtheirus salmonis, Glucosinolates, Functional feeds,
Iron, Antioxidant, Detoxification
Background
Despite significant attention given to finding alternative
control strategies of the ectoparasite salmon louse
Lepeophtheirus salmonis, the management of infections
on salmon farms still heavily relies on the use of chem-
ical treatments [1]. Several recent studies describe the
severity of the situation in detail, including incurred eco-
nomic losses [2], mortalities associated with application
of chemical treatments [1] and in wild salmonid popula-
tions [3–5], risk of pathogenic virus transmission [6–8],
and development of resistance to available parasiticides
[9–12]. As chemical treatments are becoming limited
and less efficient, there is an increasing interest in the
development of anti-lice functional feeds.
Protection against lice can involve modulation of in-
flammation at the attachment site and induction of iron
regulatory mechanisms [13–16], processes that can be
modulated by diet [17, 18]. GLs constitute a heteroge-
neous family of sulfur-rich secondary plant metabolites
occurring in cruciferous plants that are grown and con-
sumed worldwide. Upon mechanical damage, GLs are
hydrolyzed by the enzyme myrosinase into compounds
that defend plants against a wide range of herbivores, in-
cluding insects and aquatic invertebrates (reviewed by
[19]). Ingested GLs are also hydrolyzed by the intestinal
microflora [20]. Isothiocyanates (ITCs) constitute the
major bioactive fraction of the hydrolysis products of
GLs, with antibacterial properties in vitro [21], and anti-
fungal effector properties in live plant cells [22].
GLs and related products are toxic to parasites in direct
contact, but not much is known about the mechanisms be-
hind the avoidance behavior of chemical irritation. The
ability to perceive volatile ITCs has been well documented,
especially in insects [23]. Avoidance and attractant effects
with non-host and host conditioned water respectively,
were shown in behavioral tests in vitro, in a related, also
parasitic louse species (Caligus rogercresseyi) [24]. An in
vivo follow-up study revealed activation of putative ionotro-
pic receptor genes that could possibly be involved in the ol-
faction and avoidance of salmon fed anti-lice feeds [25].
Currently, GLs and their breakdown products are
attracting attention in fish nutrition research because of
their parasiticidal potential against the sea louse species
that infect cultured salmonids. Fish receiving GLs-based
functional feeds could additionally benefit from their
detoxifying and immunomodulatory properties. Modula-
tion of cellular redox status appears to be at the core of
ITCs’ bioactivity (reviewed in detail by [26]). The indirect
antioxidant properties of ITCs achieved through induction
of phase-2 detox enzymes are considered responsible for
their anticancerogenic properties [27]. However, under
certain conditions, ITCs can also induce the pro-oxidant
phase-1 enzymes [26]. The positive effects on human
health of GLs and ITCs present in diets rich in crucifer-
ous vegetables were reported by several clinical studies
[28–31]. However, GLs can exert anti-nutritional and
toxic effects [32–36], and their wider use in aquaculture
requires better knowledge of their actions. Reduced pal-
atability and decreased growth are among the main
anti-nutritional effects of overexposure to GLs/ITCs in
vertebrates, (reviewed in [37]). When large quantities
are ingested, the adverse health effects include deterior-
ation of liver, kidney and thyroid function [37].
Here we report findings from several feeding trials
designed to investigate both the beneficial and adverse ef-
fects of GLs, alone and during the L. salmonis challenge,
on nutritional parameters, gene expression and physio-
logical responses in Atlantic salmon. In Trial 1, Atlantic
salmon not infected with lice (NI) but with an extreme in-
clusion level (13%) of the GLs-containing raw ingredient
in their diet (NI-13) were compared to the control group
with 0% dietary GLs (NI-C); hepatic, renal and muscle
transcriptomes measured by microarrays were comple-
mented with measurements of the growth response, liver
steatosis and plasma biochemistry. Trial 2 addressed the
effects of the L. salmonis infection and GLs on growth,
plasma biochemistry, and gene expression of GLs-
responsive candidates by qPCR in liver and distal kidney
of infected (I) fish exposed to control feed with 0% GLs (I-
C), medium (3.6%) (I-3.6) and extreme level of GLs (I-13).
Finally, in Trial 3, a lower range of dietary GLs (0, 0.5, 1
and 2%) were tested against L. salmonis infection. Growth,
hepato-somatic and intestinal-somatic indices, liver stea-
tosis and muscle tissue composition were measured in I-
C, I-0.5, I-1 and I-2 study groups.
Results
Fish growth
In Trial 1, no significant reduction in growth was seen
in parasite free NI-13 fish at the end of the 17–18 day
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exposure period to the extreme dose of GLs (Table 1).
After a longer exposure period (47 days), significant
(ANOVA: F(2,177) = 24.86; I-C vs I-3.6: P < 0.0001; I-C vs
I-13: P < 0.0001) growth reductions were observed in
Trial 2 in I-13 and I-3.6 groups, 17 and 14% lower in
comparison to I-C, respectively (Table 2). The calculated
condition factor (CF) was found to be very similar in NI-C
and NI-13 (Table 1), but significantly (ANOVA: F(2,177) =
11.37, I-C vs I-3.6 P < 0.0001, I-C vs I-13 P < 0.001) differ-
ent in Trial 2 (Table 2). The lower inclusion levels in Trial
3 of the GLs-containing raw ingredient in I-0.5, I-1 and I-
2 did not result in significant differences in weight and CF
between the dietary groups (Table 3). No differences in
feed consumption were found in any of the trials.
Plasma profiling
A basic panel of plasma tests was performed on parasite
free fish from Trial 1 (NI-C and NI-13) and lice infected
fish from Trial 2 (I-C, I-3.6 and I-13) (Fig. 1). The ele-
vated levels of profiled enzymes in plasma are consid-
ered good indicators of cytolysis and cell leakage [38].
Alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) are found in liver parenchymal cells,
and also in kidney, muscle and other tissues [38], while
creatine kinase (CK) is an enzyme that mainly increases
due to leakage from muscle cells [39, 40]. No differences
were found in plasma levels of ALT, AST and CK be-
tween NI-C and NI-13. Interestingly, levels of all three
profiled enzymes were lower in Trial 2 during the lice
infection in comparison to values measured in lice free
fish in Trial 1. The two trials are directly comparable as
both took place under the same conditions and at about
the same time. Cholesterol levels were also significantly
(t-test: t(56) = 2.8, P = 0.007) lower in infected fish than in
fish not exposed to lice. Bilirubin, which is predomin-
antly formed by the breakdown of heme present in
hemoglobin [38], showed the highest level in I-3.6 and
was significantly different from the level measured in I-
C and I-13 (Kruskal-Wallis H-test: χ2 = 5.99, df = 2; I-C
vs I-3.6: P = 0.02; I-13 vs I-3.6: P = 0.05). Stress causes
ionic imbalances in fish (see Djordjevic et al. [41] and
references therein). We have previously seen an increase
in sodium (Na+) ions in cortisol injected salmon during
the lice challenge [42], hence we measured Na+ and
potassium (K+) plasma levels and calculated their ratio
(Na/K) for each group. Na+ decreased in NI-13 fish
while K+ decreased in I-13, in comparison to their
respective controls (data not shown), while the Na/K
was found to be highest in I-13.
Liver steatosis
Liver steatosis results from the three trials are shown in
Fig. 2. A lowering effect of GLs on steatosis was
observed in all trials, while Trial 3 captured a smaller
lowering effect of lice infection on liver steatosis.
Organo-somatic indices and flesh quality
In Trial 3, the hepato-somatic index (HSI) and intestinal-
somatic index (ISI) were calculated based on measure-
ments taken from 10 fish from each of the study groups
(Fig. 3). The HSI declined as the inclusion of GLs
increased, being significantly (Kruskal-Wallis H-test: χ2 =
7.8, df = 3, P = 0.008) different between I-2 and I-C. GLs
showed the opposite effect on ISI, with the significant
(ANOVA: F(3,37) = 3.8, P = 0.002) difference observed be-
tween I-C and I-0.5 fish.
Flesh quality parameters were determined by the near
infrared spectroscopy (NIR) performed on Norwegian
quality cut (NQC) samples (Table 4). Almost all of the
significant changes in the fatty acid profile were observed
between I-0.5 fish and I-C, and I-2 and I-C.
Table 1 Mean weight ± standard deviation (SD) and mean
condition factor ± SD in not infected fish exposed to 0% of the
GLs-containing raw ingredient (NI-C) and 13% (NI-13) in Trial 1.
Data was analyzed by t-test
Trial 1 NI-C (n = 18) NI-13 (n = 18)
Weighta (g) 825.6 ± 117.5 805 ± 139
CFb 1.52 ± 0.08 1.56 ± 0.08
at-test: t(34) = 0.49, P = 0.62
bCondition factor was calculated by the formula (weight*100/length3) for each
individual fish. t-test: t(34) = 1.37, P = 0.18
Table 2 Mean weight ± standard deviation (SD) and condition
factor ± SD in L. salmonis-infected fish exposed to 0% of the
GLs-containing raw ingredient (I-C), 3.6% (I-3.6) and 13% (I-13) in
Trial 2. Data were analyzed by One-way ANOVA
Trial 2 I-C (n = 60) I-3.6 (n = 60) I-13 (n = 60)
Weighta (g) 871 ± 127 751 ± 121**** 726 ± 113****
CFb 1.43 ± 0.13 1.54 ± 0.16**** 1.52 ± 0.13***
***P < 0.001, **** P < 0.0001: significant differences in comparisons
with control
aANOVA: F(2,177) = 24.86, I-C vs I-3.6 P < 0.0001, I-C vs I-13 P < 0.0001
bCondition factor was calculated by the formula (weight*100/length3) for each
individual fish. ANOVA: F(2,177) = 11.37, I-C vs I-3.6 P < 0.0001, I-C vs
I-13 P < 0.001
Table 3 Mean weight ± SD and condition factor ± SD
in L. salmonis-infected fish exposed to 0% of the GLs-containing
raw ingredient (I-C), 0.5% (I-0.5), 1% (I-1) and 2% (I-2) in Trial 3
Trial 3 I-C (n = 78) I-0.5 (n = 76) I-1 (n = 72) I-2 (n = 73)
Weighta 540 ± 110 554 ± 103 540 ± 119 553 ± 103
CFb 1.2 ± 0.08 1.2 ± 0.08 1.2 ± 0.07 1.2 ± 0.05
aANOVA: F(3,292) = 0.4, P = 0.75
bCondition factor was calculated by the formula (weight*100/length3) for each
individual fish. ANOVA: F(3,291) = 1.85, P = 0.14
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Microarray analyses
Microarray analyses were performed on liver, distal kid-
ney and muscle samples from the NI-C and NI-13 fish
from Trial 1. The criteria for differentially expressed
genes (DEGs) were selected by comparison of the test
NI-13 group to NI-C, with log2-ER > 0.6 and P < 0.05.
Magnitude of diet-induced changes was similar in all tis-
sues, while the number of DEGs that met our criteria
was highest in the liver (232), followed by the distal
kidney (188) and the muscle (156).
Liver
Genes with roles in cell cycle and related processes
(chromatin organisation regulation, DNA replication and
repair) comprised a large part of differentially expressed
genes (Table 5). Increased expression was shown by sev-
eral genes involved in the negative regulation of cellular
proliferation (e.g. cullin 1b, btg1, c ostars family protein
abracl) while a suite of genes coding for proteins re-
quired for cell cycle, DNA replication and cellular div-
ision (e.g. securin, condensin complex subunit 3 and
cyclins G2/mitotic-specific cyclin-B1 and cyclin-A2) were
downregulated. Activation of detoxification genes from
both phase-1 (oxidation, reduction, and hydrolysis reac-
tions) and phase-2 (conjugation reactions that increase
water solubility of products generated by phase-1 en-
zymes) pathways was observed (Table 5). Phase-1 mono-
oxygenases cytochrome P450 24A1 (cyp24a1) may
oxidise either xenobiotics or endogenous compounds.
GLs-enriched diet also activated epoxide hydrolase
Fig. 1 Blood plasma levels (mean ± SEM) of total bilirubin (a), cholesterol (b), alanine aminotransferase (ALT) (c), aspartate aminotransferase (AST)
(d), creatine kinase (CK) (e) and sodium (Na+) to potassium (K+) ratio (Na/K) (f) in not infected (NI) fish exposed to 0% of GLs (NI-C) and an
extreme dose of GLs (NI-13) and infected fish (I) fed feed with 0% of GLs-containing raw ingredient (I-C), 3.6% (I-3.6) and 13% (I-13). Blood plasma
profiling was performed on 15 individuals from NI-C and 16 individuals from NI-13 in Trial 1, and 9 fish from each of the groups in Trial 2. Asterisks
shown between NI and I groups refer to statistical differences of NI-C and NI-13 as one group vs I-C, I-3.6 and I-13 as the other group. Asterisks
shown above bars denote significant differences between two groups. *P < 0.05, **P < 0.01
Skugor et al. Parasites & Vectors  (2016) 9:639 Page 4 of 17
(ephx) 1 and ephx 2 that have roles in the protection
from cyclic epoxides. Phase-2 detox metabolism was
represented by genes from well-known families respon-
sive to ITCs in mammals [43–46]: UDP Glucuronosyl-
transferase 1 family polypeptide b7 (ugt1b7), arylamine
N-acetyltransferase, pineal gland isozyme NAT-10 (ary1),
involved in the detoxification of hydrazine and arylamine
drugs, and glutathione S-transferase theta (gstt) 1 and
gstt3. Stimulation of biotransformation was in line with
the slight induction of stress responses witnessed by the
upregulation of glucocorticoid receptor and transcription
factor jun b. Expression of several other genes with im-
portant metabolic roles was affected. The leader among
the induced genes was CMP-sialic acid transporter
(Table 5) involved in the transfer of sialic acid into the
Golgi lumen where its conjugation to acceptor mole-
cules takes place. Pyruvate dehydrogenase kinase isozyme
2 (pdk2) is a master regulator of metabolic fluxes



























Fig. 2 a Scoring of liver steatosis by light microscopy in Trial 1, 2 and 3. Liver sections from Trial 1 (NI-C and NI-13), Trial 2 (I-C, I-3.6 and I-13) and
Trial 3 (NI- C, I-C and I-2) were scored from 0 to 5 [88], based on the degree of vacuolization in the cytoplasm and the degree of distribution of
the vacuolated hepatocytes (Additional file 1: Table S2). 4–6 fish in each group were analyzed. Solid black line shows the mean score ± SEM in
each group, and black dots show the individual fish scores. b-d Exemplary images of livers showing different level of steatosis. b Micrograph of a
fish from group I-3.6 fish (Trial 2) with a score of 0. c Micrograph of a fish from group NI-C fish from Trial 3 with a score of 1. d Micrograph of a
fish from group I-C fish from Trial 2 with a score of 3. Scale-bars: 100 μm
Fig. 3 Organ indices (mean ± SEM) in lice infected fish (I) fed inclusion levels of 0% (I-C), 0.5% (I-0.5), 1% (I-1) and 2% (I-2) of GLs. a Hepato-somatic
indices (HSI). b Intestinal-somatic indices (ISI). Number of fish in each group is 10. Asterisks denote level of significance between groups: **P < 0.01. ISI
data was analyzed by One-way ANOVA followed by Tukey’s multiple comparisons test, while HSI data was analyzed by the Kruskal-Wallis test followed
by the post-hoc Dunn’s test
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through the pathways of glucose and lipid metabolism.
Also of note was stimulation of bile salt export pump.
The observed induction of hepcidin-1 (hepc1) and cyto-
chrome b reductase 1 (cybrd1), the key regulators of iron
uptake indicated a decrease of plasma iron levels
(Table 5). Porphobilinogen deaminase, involved in heme
biosynthesis, and probable cytosolic iron-sulfur protein
assembly protein ciao 1, key component of the cytosolic
iron-sulfur protein assembly complex, were downregu-
lated. Dietary suppression of a handful of immune genes
was observed in the NI-13 group while a few negative
regulators of immune responses were found among up-
regulated genes (data not shown). In contrast, we ob-
served the hepatic induction of four complement system
genes (Table 5).
Distal kidney
A suite of genes involved in xenobiotic metabolism were
upregulated (Table 6). NAD(P)H dehydrogenase quinone
1 (nqo1) is a highly-inducible gene coding for a multi-
functional antioxidant enzyme that is typically coordi-
nately regulated with other detoxifying genes responsive
to ITCs [47]. Several genes that could serve as inhibitor
of calcification and renal stone formation included the
upregulated fetuin-A [48] (Table 6) and serine-pyruvate
aminotransferase, mitochondrial with double metabolic
roles, gluconeogenesis in mitochondria and peroxisomal
detoxification of glyoxylate (Table 6). The latter function
prevents calcium oxalate kidney stone formation [49].
Leptin, which was induced by diet containing GLs, may
contribute to the deterioration of renal function through
fostering proteinuria and TGFβ-mediated deposition of
proteins in the extracellular matrix (ECM) [50] (Table 6).
Multiple indications support this claim. Two inhibitors of
TGFβ signalling were suppressed; TGFβ-1-induced tran-
script 1 protein that also regulates Wnt pathway and TGFβ
receptor III that could act as a decoy receptor involved in
capturing and retaining TGFβ [51]. Increased expression
of collagen a3(I) was in parallel with downregulation of
procollagen C-endopeptidase enhancer 1 that enhances
collagen degradation. Upregulation of microfibrillar-asso-
ciated protein 1, component of the elastin-associated
extracellular microfibrils and fibrinogen alpha chain could
contribute to deposition of extracellular insoluble fibrils,
which cause progressive renal dysfunction [52]. As could
be expected, a group of genes that might play protective
roles against renal fibrosis was simultaneously activated by
exposure to the high dose of dietary GLs, including ski-
interacting protein that inhibits TGFβ-mediated re-
sponses [53], Wnt-5b that inhibits activation of the
canonical (pro-fibrotic) Wnt pathway [54] and matrix
metalloproteinase 9 involved in digestion of ECM
(Table 6). We also observed regulation of a number of
immune genes (data not shown), some of which have
known anti-fibrotic properties [55], such as interferon γ
(ifnγ) (Table 6) or might act as pro-fibrotic factors and
contribute to tissue damage. Regulation of iron metab-
olism was supported by the expression of two sidero-
flexins and one ferritin gene (Table 6).
Muscle
Proapoptotic and inhibitory effects on proliferation in the
muscle tissue were inferred from upregulated genes
(Table 7), including actin-related protein 2/3 complex sub-
unit 1B, involved in the regulation of actin polymerization
[56]; Bax that by antagonizing one of the apoptosis repres-
sors accelerates programmed cell death [57], and andro-
gen-induced proliferation inhibitor that plays a role in
proliferative arrest [58]. Further support came from the
downregulated heparin-binding growth factor 1 that pro-
motes cardiac hypertrophy and smooth muscle cell prolif-
eration [59] (Table 7). Many genes with roles in diverse
aspects of muscle-biology were regulated; myosin Va has a
role in actin filament-based movement [60]; four and a
half LIM domains protein 1 [61] has a role in muscle de-
velopment or hypertrophy; sodium/hydrogen exchanger is
involved in muscle remodeling [62]; tetranectin is involved
in muscle regeneration and muscle cell differentiation
[63]; myotubularin plays a role in skeletal muscle main-
tenance [64]; and protein arginine methyltransferase 5 is
required for myogenesis and is also a positive modulator
of insulin-mediated glucose uptake in skeletal muscle cells
[65]. Active remodeling of intracellular structures in
muscle tissue was evidenced by upregulation of stathmin,
which disrupts the microtubule array [66] (Table 7).
Microtubule-associated protein 1 light chain 3 alpha and
tripartite motif-containing 55b that plays regulatory roles
in the myofibril assembly [67] were induced by the GLs-
enriched diet. The suppressed aryl hydrocarbon receptor 2
beta (ahR2b) indicated fine-tuning of selected phase-1
Table 4 Near infrared spectroscopy (NIR) of Norwegian quality
cut (NQC) samples from Trial 3
Trial 3 14:0a 16:0b 18:1c 22:6n-3d
(n = 10) (n = 10) (n = 10) (n = 10)
I-0.5 3.23 ± 0.05** 15.85 ± 0.37** 29.18 ± 0.38 7.52 ± 0.20**
I-1 3.31 ± 0.07 14.94 ± 0.47 29.49 ± 0.76 7.80 ± 0.20
I-2 3.37 ± 0.06 15.82 ± 0.32** 28.01 ± 0.65* 7.78 ± 0.21*
I-C 5.78 ± 1.55 12.67 ± 1.34 23.47 ± 2.66 8.64 ± 0.28
Values are shown as mean ± SEM. *P < 0.05, ** P < 0.01: significant differences
in comparison with control
a14:0 Kruskal-Wallis H-test: χ2 = 7.8, df = 3, P = 0.01
b16:0 Kruskal-Wallis H-test: χ2 = 7.8, df = 3, P = 0.027; I-0.5 vs I-C P = 0.0096; I-2
vs I-C P = 0.009
c18:1 Kruskal-Wallis H-test: χ2 = 7.8, df = 3, P = 0.03
d22:6n-3 ANOVA: F(3,34) = 4.5; I-0.5 vs I-C P = 0.0064; I-2 vs I-C P = 0.05)
Lice infected (I) fish were fed inclusion levels of 0% GLs-containing raw
ingredient (I-C), 0.5% (I-0.5), 1% (I-1) and 2% (I-2). Levels of 14:0, 16:0, 18:1,
22:6n-3 are shown, as they were the only parameters that were significantly
different in the One-way ANOVA or Kruskal-Wallis test
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and −2 cytochrome P450 isoforms, as has been described
for the ahR2b mammalian counterpart [68] (Table 7).
Glutathione transferase omega-1 (gsto1) with dual roles in
Ca-mediated muscle contraction, and cellular redox
homeostasis as phase-2 biotransformation enzyme [69]
was also upregulated (Table 7). The gene 6-phosphoglu-
conolactonase (pgls), coding for an enzyme required for
the functioning of the pentose phosphate pathway when
the rate of oxidation of NADPH is accelerated [70], was
also induced. Increased expression of pgls could contrib-
ute to decreased lifetime of 6-phosphogluconolactone, its
highly reactive and potentially toxic substrate. Alcohol de-
hydrogenase class-3 (adh3), also induced, constitutes the
primary defence mechanism against formaldehyde damage
and may also indirectly mediate protection of proteins
against oxidation [71]. Gene encoding heme oxygenase 1
(ho-1) that has important antioxidant and cytoprotective
activities was the most highly induced gene by dietary GLs
in muscle (Table 7). Previously, it was shown that ITCs-
mediated induction of heme degrading HO-1 exerts
protective effects in kidney [72]. Together with activation
of uroporphyrinogen decarboxylase, involved in heme
biosynthesis, these findings suggest increased turnover of
heme under GLs exposure.
qPCR analyses
qPCR analyses were used to validate microarray data
and, in addition, compare responses of lice-challenged
salmon under the low (3.6%) and extreme dose (13%) of
GLs to lice free and lice infected fish given control feed.
Table 5 Differentially expressed genes in the liver of not
infected (NI) salmon fed an extreme dose of GLs-containing raw
ingredient (NI-13) in comparison to NI salmon fed 0% dietary
GLs (NI-C). Data are log2-ER
log2-ER
Negative regulation of proliferation
Cullin 1b 1.82
Btg1 1.66
Costars family protein abracl 1.61
NOD-like receptor C 1.42
HIV-1 Tat interactive protein 2 1.01
Nitrilase homolog 2 0.90
Positive regulation of proliferation
Transmembrane protein 53 -1.17
Cell division cycle protein 23 homolog -1.20
Cyclin-A2 -1.21
Arntl2 protein -1.23
Ornithine decarboxylase 1 -1.29
G2/mitotic-specific cyclin-B1 -1.47
Placenta-specific gene 8 protein -1.62






Ribonucleoside-diphosphate reductase large subunit -1.03
Chromatin regulation
Histone deacetylase 2 -1.00
DnaJ homolog subfamily C member 2 -1.06
Lamin B receptor -1.21
Condensin complex subunit 3 -1.56
DNA damage and repair
Uracil-DNA Glycosylase -1.06
Ubiquitin carboxyl-terminal hydrolase isozyme L5 -1.18
Biotransformation/detoxification
Cytochrome P450 24A1, mitochondrial precursor 1.51
Glucocorticoid receptor 1.51
Arylamine N-acetyltransferase, pineal Gland isozyme NAT-10 1.38
Transcription factor jun-B 1.25
Glutathione S-transferase 3 1.00
Glutathione S-transferase theta-1 0.93
Epoxide hydrolase 1 0.85
Epoxide hydrolase 2 cytoplasmic 0.92




Table 5 Differentially expressed genes in the liver of not
infected (NI) salmon fed an extreme dose of GLs-containing raw
ingredient (NI-13) in comparison to NI salmon fed 0% dietary
GLs (NI-C). Data are log2-ER (Continued)
CMP-sialic acid transporter 2.00
Pyruvate dehydrogenase kinase isozyme 2, mitochondrial
precursor
1.54




Novel protein similar to vertebrate scavenger receptor protein -1.60
Iron metabolism
Hepcidin-1 1.60
Cytochrome b reductase 1 1.29
Porphobilinogen deaminase -0.98
Probable cytosolic iron-sulfur protein assembly protein ciao 1 -0.92
Complement immune response
Complement factor H precursor 1.33
Properdin P factor 2 1.04
Properdin P factor 3 0.94
Complement C1q-like protein 4 0.88
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Three complement genes that were not measured by the
microarray in liver were analyzed by qPCR (complement
c3 (c3), complement c5 (c5) and complement component
1Q binding (c1qbp)), as several other genes of the com-
plement system indicated complement activation in NI-
13 (Table 5). Microarray results shown next to qPCR re-
sults of NI-13 in Figs. 4, 5 (two first bars), revealed high
concordance between the two platforms. Ary1, involved in
detoxification, and complement factor H (cfh) and c3, in-
volved in the complement immune response, showed simi-
lar level of activation in lice challenged fish. Cyp24a1, a
phase-1 detoxification gene and a complement regulator
c1qbp were significantly (cyp24a1: t-test: t(15) = 2.2, P =
0.04; c1qbp: t-test: t(15) = 2.4, P = 0.03) responsive to the
high dose of GLs without lice (NI-13). pdk2 was signifi-
cantly induced only in I-C (t-test: t(15) = 3.121, P = 0.007)
group. Tyrosinedegrading 4-hydroxyphenylpyruvate dioxy-
genase (hpd) was the most highly induced gene in NI-13
on the distal kidney microarray. Elevated levels of tyrosine
in the absence of HPD activity are toxic to kidney [73, 74].
qPCR analyses revealed most statistically significant (t-test:
t(15) = 4.2, P = 0.0007) upregulation of hpd in I-3.6 salmon.
I-13 group showed highest level of solute carrier family 13
member 3-like (slc13a3), while during infestation, ifnγ and
integrator complex subunit 7 (ints7) were most highly in-
duced under the lower dose of GLs, in I-3.6 salmon. Ifnγ,
also highly induced in NI-13, is protective against renal in-
jury induced by arsenite by modulation of detoxification
pathways [75] and experimental renal fibrosis following
chemotherapeutic exposure, explained by increasing the
viability of renal tubular cells [76]. Slc13a3 is highly
expressed on the basolateral membrane of proximal kid-
ney tubule cells, contributes to heavy metal detoxification
[77, 78] and is involved in the selective uptake of Krebs
cycle intermediates [77]. Ints7 plays a role in the DNA
damage response pathway that typically results in cell cycle
arrest [79]. qPCR analysis revealed appreciable induction
of leptin in I-13 (6-fold compared to NI-C) while I-C and I-
3.6 groups showed slight downregulation. The knockout of
abhydrolase domain-containing protein 6 (abhd6), which
was significantly (t-test NI-C vs I-13: t(15) = 2.1, P = 0.05; I-
C vs I-13: t(16) = 3.1, P = 0.0074) induced in I-13 fish, re-
sults in downregulation of genes involved in de novo fatty
acid synthesis and lipogenesis in murine kidney [80].
Discussion
The interest for GLs and their breakdown products in
Atlantic salmon aquaculture lies in their parasiticidal po-
tential against salmon louse, alongside beneficial effects
related to the improvement of the antioxidant status and
detoxification abilities. However, based on knowledge
from vertebrate studies, both adverse and positive effects
of dietary GLs could be anticipated. An undesired conse-
quence, most pronounced at the extreme dietary level of
Table 6 Differentially expressed genes in distal kidney of not
infected (NI) salmon fed an extreme dose of GLs-containing raw
ingredient (NI-13) in comparison to NI salmon fed 0% dietary
GLs (NI-C). Data are log2-ER
log2-ER
Biotransformation, detoxification
Solute carrier family 22 member 2 1.41
NAD(P)H dehydrogenase quinone 1 1.26
Serine–pyruvate aminotransferase, mitochondrial precursor 1.24
Glutamate-cysteine ligase catalytic subunit 0.95
Epoxide hydrolase 2 -0.90
Oxidation-reduction processes
Sarcosine dehydrogenase 1.11
Ubiquinol-cytochrome c reductase core I protein 1.02
Cytochrome B -0.94













Extracellular matrix components and regulation
Fibrinogen alpha chain 1.07
Wnt-5b 1.06
Collagen a3(I) 0.98
Microfibrillar-associated protein 1 0.86
Transforming growth factor, beta (TGFβ)- receptor III -1.02




Matrix metalloproteinase 9 1.15
OTU domain-containing protein 6B 0.90
Prepro-cathepsin C 0.86
Proteasome subunit alpha type-1 0.83
Procollagen C-endopeptidase enhancer 1 -0.92





Ferritin, middle subunit 0.83
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GLs, was the observed reduction in growth seen in Trial
2. Microarray profiling proposed molecular players be-
hind the reduction in growth mediated by high levels of
dietary GLs. Higher mRNA levels in NI-13 in compari-
son to control were seen for a number of genes involved
in the negative regulation of proliferation in both liver
and muscle. This was in line with a number of sup-
pressed genes with roles in the development, mainten-
ance and hypertrophy of muscle in the transcriptome of
fish under the extreme exposure to GLs. In contrast, the
Table 7 Differentially expressed genes in the muscle of not
infected (NI) salmon fed an extreme dose of GLs-containing raw
ingredient (NI-13) in comparison to NI salmon fed 0% dietary
GLs (NI-C). Data are log2-ER
log2-ER
Positive regulation of proliferation
Ccr4-not transcription complex subunit 6 1.13
Placenta-specific gene 8 protein 0.98
Haspin -1.08
Negative regulation of proliferation, apoptosis
Actin-related protein 2/3 complex subunit 1B 1.35
Kruppel-like factor 11 1.26
Androgen-induced proliferation inhibitor 1.21
Tumor necrosis factor receptor superfamily member 1A 0.88
Bax 0.86
Caspase-activated DNase 0.82
Cyclin-D-binding Myb-like transcription factor 1 -0.84
DNA replication
Nuclear factor 1 1.31
DNA replication licensing factor mcm3 -0.83
DNA replication licensing factor mcm5 -1.11
DNA damage and repair
E3 sumo-protein ligase nse2 -0.88
TFIIH basal transcription factor complex helicase XPB subunit -0.89
FACT complex large subunit -1.00
Ubiquitin-conjugating enzyme E2 T -1.43
Nucleotide metabolism




Microtubule-associated protein 1 light chain 3 alpha 1.17
Tetranectin 1.07
Protein arginine methyltransferase 5 1.03
Myosin 1 1.00
Tripartite motif-containing 55b 0.84
Four and a half LIM domains protein 1 -0.81




Negative regulation of myogenesis
Cardiomyopathy associated 5 like 1.29
Stathmin 1.03
Histone deacetylase 4 -1.66
Biotranformation, detoxification
6-phosphogluconolactonase 1.21
Table 7 Differentially expressed genes in the muscle of not
infected (NI) salmon fed an extreme dose of GLs-containing raw
ingredient (NI-13) in comparison to NI salmon fed 0% dietary
GLs (NI-C). Data are log2-ER (Continued)
Glutathione transferase omega-1 1.10
Cytochrome b-c1 complex subunit 6, mitochondrial 1.01
Alcohol dehydrogenase class-3 0.84
Aryl hydrocarbon receptor 2 beta -0.86
Cytochrome P450 1A1 -0.86
Iron metabolism
Heme oxygenase 1 1.69
Proton-coupled folate transporter 1.29
NADH-cytochrome b5 reductase 1 0.94
Uroporphyrinogen decarboxylase 0.84
NADPH-dependent diflavin oxidoreductase 1 -0.96
Sideroflexin-2 -1.17
Fig. 4 Hepatic gene expression of ary1, cyp24a1 and pdk2 with roles in
metabolic adaptation to nutrient availability, complement regulator cfh,
complement components c3 and c5, and complement regulator c1qbp
measured by qPCR and shown as mean -ΔΔCt ± SEM. The first bar for
each gene shows the logER value measured by microarray in not infected
(NI) fish (n= 5) fed 13% of the GLs-containing raw ingredient (NI-13). Gene
expression in infected (I) fish fed increasing levels of GLs-containing raw
ingredient, 0% (I-C), 3.6% (I-3.6) and 13% (I-13), were measured by qPCR.
The zero is set to NI fish fed 0% dietary GLs (NI-C). Number of fish in each
group is 9. The letter “a” denotes significant expression difference to NI-C,
“aaa” when P< 0.001, “aa” when P< 0.01 and “a” when P< 0.05
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negative effect on growth was not shown in Trial 3, with
up to 2% of the GLs-containing raw ingredient included
in the feed. With respect to other potential beneficial
effects of GLs, of note was the reduction of liver steato-
sis (Fig. 2a) measured even at a low level of GLs (I-2)
and decrease of HSI in I-2 (Fig. 3a). In Trial 3, an
increase in ISI with the increasing level of GLs was re-
vealed, being highest and significant at the lowest inclu-
sion level of GLs (Fig. 3b). Interestingly, fillet quality
traits profiled by NIR for I-0.5, I-1 and I-2 fish revealed
minor differences (Table 4).
Microarrays of the distal kidney of NI-13 was charac-
terized by the concerted activation of DNA damage
response genes (Table 6), and suggested activation of
anti-fibrotic responses and those implied in the preven-
tion of renal stone formation. This was not reflected in
the level of plasma indicators of tissue damage (ALT,
AST and CK) in Trial 1 (Fig. 1). In fact, most had lower
values in NI-13 compared to NI-C. Furthermore, reduced
enzyme levels in fish from Trial 2 in comparison to fish
from Trial 1 were likely the reflection of lowered tissue
metabolic activity during the lice challenge, possibly most
affecting muscle, as judged by the drop in CK levels.
Nevertheless, evidence produced with qPCR, particularly
leptin data (Fig. 5), pointed out that I-13 fish stand an in-
creased risk of developing renal pathophysiology in case
of prolonged simultaneous exposure to high levels of the
two stressors. The increase of the Na/K ratio in I-13
(Fig. 1) could be seen as a warning sign that suggested ad-
verse alteration of the hydromineral balance in this fish in
comparison to I-C. However, the high expression level of
leptin and abhd6 seen in I-13 (Fig. 5) completely dimin-
ished in I-3.6, and moreover, the moderate level of GLs
promoted the expression of ints7 and ifnγ, the latter of
which has numerous documented protective roles in the
mammalian kidney.
Expectedly, GLs stimulated the expression of genes
involved in detoxification. In contrast to the long-held
notion that GLs-derived ITCs selectively activate phase-2
while suppressing phase-1 detoxification pathways [26, 81],
our data revealed activation of a diverse group of genes
related to both pathways. In addition to the well-
documented antioxidant properties of ITCs related to
induction of phase-2 enzymes [26], their pro-oxidant prop-
erties are likely related to the simultaneous induction of
phase-1 enzymes. Phase-1 detoxification is dominated by
reactions involving cytochrome P450 enzymes, which are
abundantly present in the endoplasmic reticulum in liver
and kidney. Hepatic induction of cyp24a1 and two epoxide
hydrolases (ephx1 and 2) from phase-1 (Table 5) occurred
in parallel with the suppression of ephx2 in kidney
(Table 6), and cytochrome p450 1a1 and ahR2b, which reg-
ulates P450 enzymes, in muscle (Table 7). Activation of
genes from phase-2 metabolism was prevalent in all three
tissues. The extreme GLs-enriched diet induced key genes
required for glutathione (GSH) based detoxification pro-
cesses that result in formation of water-soluble products
that can be easily excreted. Glutamate-cysteine ligase cata-
lytic subunit encoding the first rate-limiting enzyme of
glutathione synthesis was upregulated in distal kidney
(Table 6) while glutathione transferases that catalase conju-
gation of GSH to xenobiotic products of phase-1 detoxifi-
cation steps, were induced in liver (gstt1 and gstt3)
(Table 5) and muscle (gsto1) (Table 7). Furthermore, ob-
served increase in the expression of nqo1 in distal kidney
(Table 6), ary1 and ugt1b7 in liver (Table 5), and pgls and
adh3 in muscle (Table 7), may all contribute to the better
protection against xenobiotics in fish exposed to dietary
GLs. Another potentially important effect of GLs is regula-
tion of iron metabolism in all three tissues. Levels of bio-
available iron are determined by intestinal absorption and
macrophage recycling of iron from hemoglobin. Hepc1 is a
liver peptide that modulates intestinal iron absorption and
acts to attenuate iron release from tissue macrophages and
hepatocytes. Hepatic induction of hepc1 and cybrd1
(Table 5) in fish exposed to GLs could result in increased
iron sequestration in liver, thus lowering iron plasma levels.
Most of the intracellular iron is used in mitochondria for
heme biosynthesis or in cytoplasm for the assembly of
iron-sulfur clusters that are incorporated into extra-
Fig. 5 Renal gene expression of hpd from the tyrosine breakdown
pathway, anti-fibrotic ifnγ, slc13a3 involved in the maintenance of
citrate levels, pro-fibrotic leptin, the DNA damage response gene
ints7, and abhd6 with functions in the regulation of lipogenesis in
kidney, measured by qPCR and shown as mean -ΔΔCt ± SEM. The
first bar for each gene shows the logER value measured by microarray
in not infected (NI) fish (n = 5) fed feed with 13% inclusion level of
GLs-containing raw ingredient (NI-13). Gene expression in infected (I) fish
fed increasing levels of GLs-containing raw ingredient, 0% (I-C), 3.6%
(I-3.6) and 13% (I-13), were measured by qPCR. The zero is set to NI fish
fed 0% dietary GLs (NI-C). Number of fish samples in each group is 9.
The letter “a” denotes significant expression difference to NI-C, and “b”
denotes significant expression difference to I-C, “aaa” when P< 0.001,
“aa/bb” when P< 0.01 and “a/b” when P< 0.05
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mitochondrial iron/sulfur containing proteins. Cellular iron
status determines the extent of iron-sulfur cluster assembly
and thereby regulates expression of genes for iron storage,
transport, and utilization. Concomitant downregulation of
porphobilinogen deaminase, involved in heme biosynthesis
provided solid indication that iron excess stimulates cyto-
solic FeS cluster biogenesis (Table 5). Renal induction of
ferritin, involved in iron sequestration within cells, add-
itionally supported possibility that the access of iron to cir-
culation was reduced by GLs (Table 6). Furthermore, the
most highly induced gene in muscle was ho-1 (Table 7), an
enzyme with the key role in degradation of heme into iron
and biliverdin, which is then converted to bilirubin [82].
Iron tissue dynamics within salmonid hosts is believed to
play an important role in the outcome of lice infections
[16]. Coordinated and early changes in the expression of
genes involved in metabolism of iron and erythropoiesis in
spleen, head kidney and liver were seen in lice-infected At-
lantic salmon [83, 84]. The resistant pink salmon showed
highly diverse iron sequestration and homeostasis mecha-
nisms, including an early upregulation in the head kidney
of hepc1, ho-1 and several genes involved in iron tissue
storage and sequestering of iron from blood [16]. Bilirubin
that is predominantly formed by breakdown of heme
present in hemoglobin showed highest level in the best-
protected infected group (I-3.6, Fig. 1). The observed in-
crease in bilirubin was likely not caused by liver damage,
as levels of ALT and AST went down during the lice infec-
tion. With respect to protection against the parasite, of
note are also decreased levels of cholesterol in all infected
dietary groups in comparison to NI fish. Cholesterol
deprivation of lice by the infected host can limit their
growth. This was also implied in our recent study where
estrogen-mediated protection was associated with a regu-
lation of skin genes involved in cholesterol metabolism,
among several other potentially beneficial processes [18].
Lepeophtheirus salmonis, which is an obligate parasite,
lacks genes required for the cholesterol biosynthesis
encoded in its genome (Prof. Frank Nilsen, personal
communication).
Profiling of skin of lice-infected fish from the GLs feed-
ing trial revealed reduced number of attached lice and
massive activation of antiviral responses, likely including
IFN-mediated responses [17]. The type and magnitude of
immune responses at the site of parasite attachment in
skin [13, 15] and in internal immune organs [85] contrib-
ute to susceptibility to L. salmonis in Atlantic salmon.
Several complement system genes responded to GLs in
NI-13 – this type of immune system preconditioning by
diet could be helpful upon parasite encounter.
Conclusions
Our findings encourage future use of GLs-based feeds
due to their beneficial effects on the expression of genes
with detoxifying and iron-regulatory roles in multiple
fish tissues. The further refinement of anti-lice func-
tional feeds will require understanding of how the bene-
ficial processes can be promoted to achieve protection
against lice while not decreasing growth or posing any
adverse effects on tissue functions.
Methods
Preparation of feeds and fish trials, production of feeds
and copepodids
The trials were approved by the National Animal Research
Authority, in line with the “European Convention for the
Protection of Vertebrate Animals used for Experimental
and other Scientific purposes” were performed at Ewos
Innovation in Dirdal, Norway. Feeds with various inclu-
sion levels of glucosinolates (GLs) were produced at the
Ewos Innovation plant in Dirdal, Norway. The GLs were
added to feeds by spraying the powdered raw ingredient
onto the base pellet under vacuum conditions. Air pres-
sure was then allowed to return to normal and the GLs-
containing powder was sucked into the core of the pellet.
All diets had a pellet size of 5 mm. An overview of trials,
harvested samples and applied analysis methods are
shown in Additional file 1: Table S1. The study groups
were denoted by trial (Trial 1 and Trial 2), treatment (not
infected - NI or infected - I) and the level of ingredient
(0% - C, 3.6 or 13% inclusion level).
The graphical overview of Trial 1 and Trial 2 is shown
in Fig. 6. Fish in six tanks with 18 fish in each were fed
the 0% GLs control feed for one month (acclimation) be-
fore separation of fish into two groups (Trial 1). Fish in
three tanks continued on the control feed (NI-C) while
fish in three other tanks were given the 13% GLs feed
(NI-13) during 17–18 days. At the end of this period
weight and length measurements (n = 18 in each group)
and samples of liver, muscle and distal kidney (n = 9 in
each group) were taken. Tissue samples were placed in
RNAlater (Ambion®, Austin, TX, USA) and stored at 4 °C
for 24 h and then stored at −80 °C until further analyses.
In addition, 5 liver samples from each group were placed
in neutral buffered formalin for histology. In Trial 2, fish
in tank triplicates received control diet, and diets enriched
with 3.6 and 13% of the GLs-containing raw ingredient
during three weeks. There were 90 fish in each feed group
(control, 3.6 and 13). The amount of uneaten pellets was
recorded weekly to calculate the feed intake for each of
the feeds over three weeks. After this, all 15 tanks were
given a control feed (EWOS Opal) for 10 days, and num-
ber of fish in each group was reduced to 60. This was
followed by feeding fish (n = 20 in each tank) control feed,
3.6 and 13% GLs enriched feeds in tank triplicates for
12 days (pre-infection period), and throughout the 31–35
day period of L. salmonis infection (post-infection period).
During a sampling period of 4 days, number, stage and
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gender of lice on each fish were recorded. Furthermore,
liver and distal kidney tissues were sampled in RNAlater
from 9 fish in each group. In addition, 4–6 liver samples
from each group were placed in neutral buffered formalin
for histology. The treatment groups tested in this part
were named: infected control (I-C), infected 3.6 (I-3.6)
and infected 13 (I-13). Fulton’s condition factor was calcu-
lated by the formula: (100 BWFL−3) [86] in both Trial 1
and Trial 2. Finally, peripheral blood from the caudal vein
was collected into heparinized vacutainers from fish in
each group in Trial 1 (n = 15–16) and Trial 2 (n = 9).
Fish tanks used in both trials were 500 l circular flow-
through tanks with an average temperature of 8.7 °C
and 27.4 ppt salinity.
Trial 3 was performed in August 2013 with low inclu-
sion levels of the GLs-containing raw ingredient (0, 0.5,
1 and 2%). Groups in this trial were thus infected
control (I-C), infected 0.5% (I-0.5), infected 1% (I-1) and
infected 2% (I-2) and each group of fish was allocated
into three tank replicates with 23–26 fish in each tank.
Tank conditions, feeding regime and infection of fish
with copepodids were similar to the infection study in
Trial 1 and 2 [17], but fish were fed the experimental
diets for 23 days before lice challenge, and sampling was
performed after 26–28 days of infection. At this time
point, Norwegian Quality Cut (NQC) samples were
harvested from 10 fish from each group according to the
standard procedure. Liver samples (4–6) from each group
were placed in neutral buffered formalin for histology. In
addition, hepato-somatic and intestinal-somatic indices
were calculated from 10 fish from each group, performed
by weighing the liver and intestinal mass of each fish re-
spectively and dividing this value by the fish weight.
Statistical differences of weights, CFs and organoso-
matic indices were assessed by One-way ANOVA with
subsequent Tukey's multiple comparisons test in the
GraphPad Prism Software 6.0 as criteria for Gaussian
distribution were met by Shapiro-Wilkes test and in
addition the equal variance test (Brown-Forsythe).
Students t-test was used for analyzing weights and CF in
Trial 1. The level of significance for all analyses was set
at P < 0.05.
Challenge with salmon lice
Challenge trial were performed as described in [17]. In
short, the lice population used in Trial 2 and 3 originated
from a nearby location (Oltesvik), and were maintained on
Atlantic salmon hosts kept in 850 l circular flow tanks at
the Ewos Innovation salmon lice lab. Before infection, the
copepodid density was measured in a zooplankton count-
ing chamber, where at least 4 samples were counted to
ensure accuracy of estimation. Experimental infection was
Fig. 6 Experimental setup of Trial 1 and Trial 2 (modified from [17]). Trial 1. Feed study. To study responses of the feed (without infection), Atlantic salmon
were fed control feed and high level (13%) of GLs-containing raw ingredient. All fish received control feed for 30 days during the acclimation period.
Sampling of tissues and weighing of the fish from two groups [not-infected control group (NI-C) and not-infected 13% group (NI-13)] were performed
17–18 days after feeding experimental feeds. Trial 2. Feed intake and lice challenge study. Atlantic salmon were exposed to feeds containing 0, 3.6 and 13%
of GLs for 21 days. Control feed was then fed for 10 days during the acclimation period. The trial continued with fish exposed to control, and 3.6 and 13%
GLs feeds for 12 days (pre-infection period). The tissue sampling, weighing and lice counting from the three dietary groups [infected fish fed control feed
(I-C), infected fish fed 3.6% GLs feed (I-3.6) and infected fish fed 13% GLs feed (I-13)] challenged with L. salmonis (50 copepodids per fish) were accomplished
after 31–35 days of infection (post-infection period)
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performed with 50 copepodids per fish. During the tissue
sampling period of 4 days, when most lice had reached
the preadult stages, recordings of the exact number, stage
and gender of lice on each fish were made.
RNA extraction and gene expression analysis
RNA extraction
Nine tissues samples of approximately 5 × 5 mm in size
were excised from the fish and put in RNAlater at 4 °C
and then to 80 °C until further use. Total RNA extrac-
tion was performed by the RNeasy Mini Kit (Qiagen)
and Trizol (GIBCO, Life Technologies). In brief, Trizol
(GIBCO, Life Technologies, Carlsbad, CA, USA), zirco-
nium oxide beads (VWR, Oslo, Norway) and approxi-
mately 50 mg of tissue was homogenized in FastPrep-24
homogenizer (MP Biomedicals, Santa Ana, CA, USA).
Chloroform was added to separate RNA into the super-
natant, which was subsequently run through the RNAeasy
Mini Kit clean-up procedure provided by Qiagen (Hilden,
Germany). The RNA was diluted with 30 μl of RNAse free
H2O, concentration was determined by spectrophotom-
etry using NanoDrop ND1000 (Nanodrop Technologies,
Wilmington, DE, USA) and stored at -80 °C. Integrity of
RNA was assessed with Agilent 2100 BioAnalyzer
(Agilent, Santa Clara, CA, US) and RNA Nano kits, and
only samples with RNA integrity number (RIN) of 8 or
higher were used for microarray.
Microarray analyses
All reagents used in the microarray procedure were from
Agilent Technologies. Liver, distal kidney and muscle
samples (n = 5) from fish from each group (NI-C, NI-13)
in Trial 1 were analyzed by microarray, and compared to
pooled controls of two fish from each diet from the
same organ. The test samples and pooled controls were
labelled with respectively Cy5 and Cy3, 100 ng of RNA
per reaction, by using The Two-colour Quick Amp
Labelling kits and Gene Expression Hybridization kits.
The hybridization step lasted 17 h at 65 °C with rotation
speed 10 rpm, followed by immersion for one minute each
in Gene Expression Wash Buffer I at room temperature
and subsequently washing in Gene Expression Wash
Buffer II at 37 °C. By scanning slides using GenePix
Personal 4100A scanner with 5 um resolution and manu-
ally adjusted laser power, an equal intensity ratio between
Cy3 and Cy5 channels with minimal oversaturation was
achieved. GenePix pro software 6.0 was used for feature
extraction, assessment of spot quality, and spot-grid
alignment. Low quality spots were flagged by the soft-
ware, and Lowess normalization of log2-expression ra-
tios (ER) was performed. Differentially expressed genes
(DEGs) were selected by comparison with not infected
control (NI-C): log2-ER > 0.6 and P < 0.05 in at least one
group. Nofima’s bioinformatics system (STARS) [87] was
used for data analyses.
cDNA synthesis and qPCR protocol
For qPCR analysis, RNA from 9 fish from the Trial 1
groups; NI-C, NI-13, and Trial 2 groups; I-3.6, I-13 and
I-C, were used. NI-C from Trial 1 was deemed as an ap-
propriate control for fish in Trial 2 as both trials took
place under the same environmental conditions in the
Salmon Lice Lab in Dirdal and with negligible time dif-
ference; less than a week passed between the two sam-
plings. RNA was reverse transcribed to cDNA by using
the cDNA Affinity Script (Agilent Technologies, Matriks
AS, Oslo, Norway) and protocol provided by the manu-
facturer. Each reaction consisted of 3 μg RNA, 1 μl of
random primers and 2 μl of oligo DT primers. The
synthesized cDNA was diluted 10 times and stored at
-20 °C until further use. The qPCR reactions were run in
duplicates. Each reaction (12 μl) contained 4 μl of
cDNA, 10 μM primers and SYBR Green I Master mix
(Roche); analyses were run in LightCycler 480 in 96 well
plates. Published gene sequences were used to design
primers (Additional file 1: Table S3) for quantitative Real
Time PCR (qPCR) reactions by CLC Workbench soft-
ware. Cycling conditions in LightCycler 480 instrument
(Roche, Applied Science) were 5 min denaturation step
at 95 °C, 40 cycles of denaturation (10 s at 95 °C), an-
nealing (20 s at 60 °C) and extension (15 s at 72 °C),
followed by melting curve analysis with measurements
of the fluorescence was performed in the temperature
range between 65 and 97 °C. The crossing point value
was found by using the maximum-second-derivative
method (Roche diagnostics), followed by the -ΔΔCt
method with comparison to reference gene elongation
factor 1 alpha (ef1α) to find the relative expression of
target genes. No signs of gDNA contamination were
found by running a subset of RNA samples together
with ef1a and SybrGreen. Specificity and efficiency were
confirmed by melting curve analysis, agarose gel electro-
phoresis and two-fold serial dilutions of cDNA for each
primer pair in triplicates. PCR efficiency of all genes
ranged from 1.96 to 2. Data were analyzed with students
t-test in the GraphPad Prism Software 6.0 if criteria for
Gaussian distribution were met by Shapiro-Wilkes test.
All qPCR data showed equal variance by the Brown-
Forsythe test. If criteria for normality were not met, the
Mann-Whitney test was used. The level of significance
for all analyses was set at P < 0.05.
Histology
Four to six fish selected randomly from each group in
Trial 1; NI-C and NI-13, Trial 2; I-C, I-3.6 and I-13, and
Trial 3; I-2 group, NI-C and I-C were subjected to histo-
logical analysis. Liver samples were fixed in neutral
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buffered formalin for 48 h with the change of formalin
after 24 h followed by dehydration, paraffin-embedding,
sectioning and haematoxylin and eosin (HE) staining by
standard histological procedures. The 4 μm blinded sec-
tions were examined with a Leica DFC 420 microscope
equipped with a digital imaging system (Leica Image
Analysis). Steatosis scoring was performed by studying
five representative fields at 20× original magnifications,
selected randomly. The areas were scored for microvesi-
cular and macrovesicular steatosis following the scoring
system and method described in [88] and in Additional
file 1: Table S2. A proportion of the liver samples were
also stained with Periodic-Acid Schiff (PAS) to exclude
glycogen accumulation as a cause of vacuole formation.
Blood plasma profiling
Blood plasma profiling was performed on 15 individuals
from NI-C and 16 individuals from NI-13 in Trial 1, and
9 fish from each of the groups in Trial 2. The full auto-
matic Adria 1800 system in the Central clinical labora-
tory at the Norwegian University of Life Sciences was
used to measure a basic panel of plasma parameters, in-
cluding ALT (alanine aminotransferase), AST (Aspartate
aminotransferase), CK (Creatine Kinase), Cholesterol,
Na (sodium), K (potassium) and bilirubin. All parame-
ters except the ions were found by measuring the optical
density at a given absorbance. Na and K levels were
assessed by the indirect potentiometric procedure.
Significant differences for each plasma parameter were
analyzed between Trial 1 and Trial 2, treating the groups
in each trial as one. Significant differences between were
also assessed between the groups in Trial 1 and Trial 2,
separately. Data were analyzed by Student’s t-test or
One-way ANOVA with subsequent Tukey’s multiple
comparisons test in the GraphPad Prism Software 6.0 if
criteria for Gaussian distribution were met by Shapiro-
Wilkes test. All parameters showed equal variance in
Brown-Forsythe test. If criteria for normality were not
met, the Mann-Whitney or the Kruskal-Wallis test was
used followed by the post-hoc Dunn’s test. The level of
significance for all analyses was set at P < 0.05.
Near infrared spectroscopy
Near infrared spectroscopy (NIR) is a spectral method
based on the fact that different feed components have
characteristic NIR absorption bands when exposed to
specific wavelengths of infrared light. NIR analysis was
performed on NQC samples from 10 individuals from
each group from Trial 3 by using the NIR XDS system
(Foss, Hillerød, Denmark) at Ewos Innovation, Dirdal.
NIR calibration equations were found beforehand by ana-
lyzing 1300 NQC samples of fish ranging in size from 0.1
to 6 kg. Reference values were based on well-established
internal and external sources. Individual NQC samples
were thoroughly grinded in a meat grinder shortly after
slaughter. The groups thus analyzed were I-0.5, I-1 and I-2
in addition to I-C. The levels of ash, energy, fat, moisture,
phosphorous, protein, pigment, total monosaturated fatty
acids, and a range of fatty acids (PUFA) including: total n-3
polyunsaturated fatty acids (PUFA), Total n-6PUFA, total
PUFA, 14:0, 16:0, 16:1, 18:0, 18:1, 18:2n-6, 18:3n-3, 18:3n-
6, 18:4n-3, 20:1, 20:3n-3, 20:3n-6, 20:4n-3, 20:4n-6, 20:5n-
3, 22:1, 22:4n-6, 22:5n-3, 22:5n-6, 22:6n-3 were analyzed.
Statistical differences were assessed by One-way ANOVA
with subsequent Tukey’s multiple comparisons test in the
GraphPad Prism Software 6.0 if criteria for Gaussian
distribution were met by the Shapiro-Wilkes test and in
addition the equal variance test (Brown-Forsythe). If
criteria for normality were not met, the Kruskal-Wallis test
was used followed by the post-hoc Dunn’s test. The level of
significance for all analyses was set at P < 0.05.
Additional file
Additional file 1: Table S1. An overview of samples and analysis
methods applied in Trial 1, 2 and 3. Table S2. Scoring of liver steatosis in
individual sections based on [88]. Table S3. Primer list. (DOCX 20 kb)
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